Daily News Podcast

Lorcaserin shows cardiovascular safety

Publish date: August 27, 2018

 

Lorcaserin is the first weight-loss drug proven to have cardiovascular safety. Also today, live attenuated flu vaccine gets the nod for upcoming flu season, PCSK9 inhibition helps patients with metabolic syndrome, and breastfeeding may reduce the risk of stroke decades later. Subscribe to the MDedge Daily News wherever you get your podcasts.

Amazon Alexa
Apple Podcasts
Spotify

Recommended Reading

Second-hand smoke sends teens to ED
MDedge Endocrinology
Mobile contraception app gets FDA approval
MDedge Endocrinology
Variation doesn’t mean quality when it comes to diet
MDedge Endocrinology
Medicare Advantage pushback
MDedge Endocrinology
Cardiovascular risk management supported for type 2 diabetes
MDedge Endocrinology
An epidemic of non-alcoholic fatty liver disease
MDedge Endocrinology
Sleepio app tied to reducing insomnia, depression
MDedge Endocrinology
5 digital HIPAA myths
MDedge Endocrinology
Screen for cervical cancer based on age, risk
MDedge Endocrinology
Is it time for PCPs to take over chronic HCV?
MDedge Endocrinology